GUARDION HEALTH SCIENCES INC (GHSI) Stock Price, Quote, News and Overview
NASDAQ:GHSI - Nasdaq - US40145Q5009 - Common Stock - Currency: USD
GHSI Quote, Performance and Key Statistics
3.25
-0.01 (-0.31%)
The current stock price of GHSI is 3.25 USD. In the past month the price decreased by -67.2%. In the past year, price decreased by -53.64%.
GHSI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UL | UNILEVER PLC-SPONSORED ADR | 23.37 | 139.29B | ||
| HLN | HALEON PLC-ADR | 23.6 | 45.90B | ||
| KVUE | KENVUE INC | 20.44 | 44.67B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 31.69 | 27.01B | ||
| BRBR | BELLRING BRANDS INC | 35.03 | 9.35B | ||
| COTY | COTY INC-CL A | 21.39 | 5.22B | ||
| IPAR | INTERPARFUMS INC | 29.58 | 4.41B | ||
| ELF | ELF BEAUTY INC | 24 | 4.25B | ||
| ODD | ODDITY TECH LTD-CL A | 22.48 | 2.47B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 10.69 | 1.50B | ||
| OLPX | OLAPLEX HOLDINGS INC | 11.15 | 961.23M | ||
| HLF | HERBALIFE LTD | 4.44 | 876.87M |
Related stock screener links
About GHSI
Company Profile
Guardion Health Sciences, Inc. engages in the business of developing and distributing clinically supported nutrition, medical foods, and dietary supplements. The company is headquartered in Houston, Texas and currently employs 9 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The firm sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. The company sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.
Company Info
GUARDION HEALTH SCIENCES INC
2925 Richmond Avenue, Suite 1200
Houston TEXAS 92128 US
CEO: Bret Scholtes
Employees: 9
Company Website: https://www.guardionhealth.com/
Phone: 18008735141
GUARDION HEALTH SCIENCES INC / GHSI FAQ
What is the stock price of GUARDION HEALTH SCIENCES INC today?
The current stock price of GHSI is 3.25 USD. The price decreased by -0.31% in the last trading session.
What is the ticker symbol for GUARDION HEALTH SCIENCES INC stock?
The exchange symbol of GUARDION HEALTH SCIENCES INC is GHSI and it is listed on the Nasdaq exchange.
On which exchange is GHSI stock listed?
GHSI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for GUARDION HEALTH SCIENCES INC stock?
7 analysts have analysed GHSI and the average price target is 40.8 USD. This implies a price increase of 1155.38% is expected in the next year compared to the current price of 3.25. Check the GUARDION HEALTH SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GUARDION HEALTH SCIENCES INC worth?
GUARDION HEALTH SCIENCES INC (GHSI) has a market capitalization of 4.39M USD. This makes GHSI a Nano Cap stock.
How many employees does GUARDION HEALTH SCIENCES INC have?
GUARDION HEALTH SCIENCES INC (GHSI) currently has 9 employees.
What are the support and resistance levels for GUARDION HEALTH SCIENCES INC (GHSI) stock?
GUARDION HEALTH SCIENCES INC (GHSI) has a support level at 3.24 and a resistance level at 5.35. Check the full technical report for a detailed analysis of GHSI support and resistance levels.
Is GUARDION HEALTH SCIENCES INC (GHSI) expected to grow?
The Revenue of GUARDION HEALTH SCIENCES INC (GHSI) is expected to grow by 9.56% in the next year. Check the estimates tab for more information on the GHSI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GUARDION HEALTH SCIENCES INC (GHSI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GHSI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GHSI, evaluating the profitability, health, valuation and growth aspects
- GUARDION HEALTH SCIENCES INC (GHSI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GUARDION HEALTH SCIENCES INC (GHSI) Sales and EPS estimates to see what analysts future expectations are.
- GUARDION HEALTH SCIENCES INC (GHSI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GUARDION HEALTH SCIENCES INC (GHSI) Insider and Institutional Ownership to learn about the owners and their transactions.
- GUARDION HEALTH SCIENCES INC (GHSI) Stock Chart to make your own analysis
- GUARDION HEALTH SCIENCES INC (GHSI) Latest news and press-releases to stay up to date.
Does GUARDION HEALTH SCIENCES INC (GHSI) stock pay dividends?
GUARDION HEALTH SCIENCES INC (GHSI) has a dividend yield of 153.85%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of GHSI dividend history, reliability and sustainability.
When does GUARDION HEALTH SCIENCES INC (GHSI) report earnings?
GUARDION HEALTH SCIENCES INC (GHSI) will report earnings on 2024-11-14, after the market close.
What is the Price/Earnings (PE) ratio of GUARDION HEALTH SCIENCES INC (GHSI)?
The PE ratio for GUARDION HEALTH SCIENCES INC (GHSI) is 7.56. This is based on the reported non-GAAP earnings per share of 0.43 and the current share price of 3.25 USD. Check the full fundamental report for a full analysis of the valuation metrics for GHSI.
GHSI Technical Analysis
GHSI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to GHSI. GHSI has a great financial health rating, but its profitability evaluates not so good.
GHSI Financial Highlights
Over the last trailing twelve months GHSI reported a non-GAAP Earnings per Share(EPS) of 0.43. The EPS increased by 154.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 99.1% | ||
| ROA | 41.65% | ||
| ROE | 46.34% | ||
| Debt/Equity | 0 |
GHSI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to GHSI. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -669.3% and a revenue growth 9.56% for GHSI